Source: Annual Congress 2003 - Sleep related breathing disorders and control of breathing
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Tomori, E. Szaboova, V. Donic (Kosice, Slovakia). Nocturnal cardiac dysrhythmias induced by sleep apnoea in adults with or without hypertension and coronary artery disease. Eur Respir J 2003; 22: Suppl. 45, 1184

Member's Comments

No comment yet.

Related content which might interest you: Polysomnographic characteristics and cardiac function in coronary artery disease patients with nonsleepy obstructive sleep apnoea Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea Year: 2018 Influence of obstructive sleep apnea in coronary artery disease: an 8-years-follow-up Source: Eur Respir J 2003; 22: Suppl. 45, 22s Year: 2003 Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up Source: Eur Respir J 2006; 28: 596-602 Year: 2006 Long-term effects of cardiac rehabilitation on sleep apnea severity in patients with coronary artery disease Source: International Congress 2017 – CPAP therapy Year: 2017 Heart rate turbulence: In patients with obstructive sleep apnea without coronary artery diseases Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011 Changes in extracranial arteries in obstructive sleep apnoea Source: Eur Respir J 2005; 25: 69-74 Year: 2005 Undiagnosed COPD and overlapping obstructive sleep apnoea in coronary heart disease Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017 Outcomes in coronary artery disease patients with sleepy obstructive sleep apnoea on CPAP Source: Eur Respir J, 50 (6) 1700749; 10.1183/13993003.00749-2017 Year: 2017 Clinical and polysomnographic determinants of REM predominant obstructive sleep apnoea and response to treatment in a revascularized coronary artery disease cohort Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders Year: 2020 Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006 Obstructive sleep apnoea and coronary artery disease Source: International Congress 2016 – PG18 Sleep apnoea and comorbidities Year: 2016 Impact of CPAP-therapy on cardiac structure and function in patients with obstructive sleep apnea syndrome and coprevalent arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006 High prevalence of obstructive sleep apnoea in revascularized patients with coronary artery disease – RICCADSA trial Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Effect of positive airway pressure on diastolic function in coronary artery disease patients with non-sleepy obstructive sleep apnea Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea Year: 2016 Increased incidence of coronary artery disease in obstructive sleep apnoea: a seven-year follow-up Source: Eur Respir J 2001; 18: Suppl. 33, 518s Year: 2001 Cardiovascular outcomes in patients with coronary artery disease and nonsleepy versus sleepy obstructive sleep apnoea phenotypes in the RICCADSA trial Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond Year: 2021 Association between obstructive sleep apnea syndrome and coronary atherosclerostic disease Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 Prevalence of obstructive sleep apnea among patients with resistant arterial hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 115s Year: 2005 Natural course of untreated obstructive sleep apnoea in patients with coronary artery disease in the RICCADSA trial Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing Year: 2021